Phenobarbital 65 MG/ML vialml
Ended Awarded Last action
- Contract number
- SPE2DR26FZ2LY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,268
Award facts
- Contract value 100% obligated
- $3,268.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,268.00 to AmerisourceBergen Drug Corp for the supply of Phenobarbital 65 mg/mL vials. The contract, executed on December 18, 2025, with an ultimate completion date of December 19, 2025, utilizes firm fixed pricing and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp supplies a comprehensive portfolio of pharmaceutical products to support military healthcare systems and other federal agencies. The company's extensive contract awards with the DLA Medical Supply Chain encompass a broad spectrum of medications and medical supplies across multiple therapeutic domains. This particular delivery order for Phenobarbital—a barbiturate used in neurological and seizure management—reflects the company's ongoing role in ensuring pharmaceutical supply continuity for Department of Defense healthcare operations. The non-set-aside status and competitive award history demonstrate AmerisourceBergen's capability to meet federal procurement requirements in an open competitive environment.
Quick answers
Who was awarded contract SPE2DR26FZ2LY?
SPE2DR26FZ2LY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 18, 2025.
How much is contract SPE2DR26FZ2LY worth?
The government has obligated $3,268 on SPE2DR26FZ2LY.
Is contract SPE2DR26FZ2LY an order under another contract?
Yes. SPE2DR26FZ2LY is a delivery order under SPE2DR25D1120, an indefinite delivery contract.
Was contract SPE2DR26FZ2LY competed?
The extent of competition for SPE2DR26FZ2LY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award